TLR2/NFκB signalling regulates endogenous IL-6 release from marrow-derived mesenchymal stromal cells to suppress the apoptosis of PC12 cells injured by oxygen and glucose deprivation

Shi,Xia; Liu,Jingjing; Yang,Ting; Zhang,Yun; Li,Tingyu; Chen,Jie

doi:10.3892/mmr.2016.5158

TLR2/NFκB signalling regulates endogenous IL-6 release from marrow-derived mesenchymal stromal cells to suppress the apoptosis of PC12 cells injured by oxygen and glucose deprivation

Authors:
- Xia Shi
- Jingjing Liu
- Ting Yang
- Yun Zhang
- Tingyu Li
- Jie Chen
View Affiliations

Affiliations: Children's Nutrition Research Centre, Children's Hospital of Chongqing Medical University, Chongqing 400014, P.R. China
Published online on: April 22, 2016 https://doi.org/10.3892/mmr.2016.5158
Pages: 5358-5364

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Two previous studies published by our group identified that mesenchymal stromal cells (MSCs) conferred neuroprotection in a rat model of hypoxic-ischaemic brain damage (HIBD), and that MSCs secreted abundant interleukin-6 (IL‑6) when co‑cultured with oxygen and glucose deprivation (OGD)‑injured PC12 cells. The present study has further investigated the role of IL‑6, and explored potential signalling pathways in vitro. In vitro models were established by co‑culturing OGD‑injured PC12 cells with MSCs. Subsequently, the expression levels of the signalling molecules, Toll‑like receptor 2 (TLR2)/nuclear factor κB (NFκB), and IL‑6 were altered separately in this in vitro model by treatment with an agonist, antagonist, siRNA or overexpression adenovirus. The expression levels of B cell lymphoma‑associated X (Bax), TLR2, NFκB and IL‑6 were detected by western blot analysis, real‑time polymerase chain reaction or ELISA. The resting membrane potential (RMP) of the PC12 cells was analysed by whole‑cell patch‑clamp recordings. Compared with controls or the PC12 co‑culture group, the MSC co‑cultured group induced less expression of Bax, but more IL‑6 secretion. Up- or down-regulation of the TLR2/NFκB signalling pathway resulted in a corresponding increase or decrease in the IL‑6 expression level in the MSCs. Co‑culture with siIL‑6‑MSCs increased the expression levels of Bax and increased the RMP in the OGD PC12 cells. In conclusion, the release of IL‑6 from MSCs was regulated via the TLR2/NFκB signalling pathway. Endogenous IL‑6 reduced apoptosis and protected OGD‑injured PC12 cells when they were co‑cultured with MSCs. The present study has reported a novel immunomodulatory effect of the microenvironment of neural damage during MSC cytotherapy.

View Figures

View References

1	Calvert JW and Zhang JH: Pathophysiology of an hypoxic-ischemic insult during the perinatal period. Neurol Res. 27:246–260. 2005. View Article : Google Scholar : PubMed/NCBI
2	Khot S and Tirschwell DL: Long-term neurological complications after hypoxic-ischemic encephalopathy. Semin Neurol. 26:422–431. 2006. View Article : Google Scholar : PubMed/NCBI
3	Kristián T: Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium. 36:221–233. 2004. View Article : Google Scholar : PubMed/NCBI
4	Bi Y, Gong M, Zhang X, Zhang X, Jiang W, Zhang Y, Chen J, Liu Y, He TC and Li T: Pre-activation of retinoid signaling facilitates neuronal differentiation of mesenchymal stem cells. Dev Growth Differ. 52:419–431. 2010. View Article : Google Scholar : PubMed/NCBI
5	Liu Y, Zhang X, Dai Y, Shu C, Qu P, Liu YX, Yang L and Li TY: Effects of bone marrow mesenchymal stem cells on learning and memory functional recovery in neonatal rats with hypoxic-ischemic brain damage. Zhonghua Er Ke Za Zhi. 46:648–653. 2008.In Chinese. PubMed/NCBI
6	Phinney DG and Isakova I: Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des. 11:1255–1265. 2005. View Article : Google Scholar : PubMed/NCBI
7	Zhang Y, Yang Y, Bi Y, Gong M, Jiang W, Wei X, Li T and Chen J: Mesenchymal stromal cell neuroprotection of hydrogen peroxide-challenged pheochromocytoma cells through reducing apoptosis and releasing cytokines. Cytotherapy. 14:954–966. 2012. View Article : Google Scholar : PubMed/NCBI
8	Winter CD, Pringle AK, Clough GF and Church MK: Raised paren-chymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain. 127:315–320. 2004. View Article : Google Scholar
9	Hüll M, Strauss S, Berger M, Volk B and Bauer J: The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res. 78:37–41. 1996. View Article : Google Scholar : PubMed/NCBI
10	Qiu Z, Sweeney DD, Netzeband JG and Gruol DL: Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci. 18:10445–10456. 1998.PubMed/NCBI
11	Erta M, Quintana A and Hidalgo J: Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 8:1254–1266. 2012. View Article : Google Scholar : PubMed/NCBI
12	Chen J, Ng CP, Rowlands DK, Xu PH, Gao JY, Chung YW and Chan HC: Interaction between enteric epithelial cells and Peyer's patch lymphocytes in response to Shigella lipopolysaccharide: Effect on nitric oxide and IL-6 release. World J Gastroenterol. 12:3895–3900. 2006. View Article : Google Scholar : PubMed/NCBI
13	Zhang Y, Gong M, Bi Y, Jiang W, Yu Q, Li TY and Chen J: Construction and identification of recombinant adenovirus vector containing siRNA of rat TLR2 gene. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 28:144–147. 2012.In Chinese. PubMed/NCBI
14	Liu JJ, Zhang YJ, Bi Y, Gong M, Li T-y and Chen J: Construction and preliminary identification of rat interleukin-6 recombinant adenovirus. Immunol J. 30:151–155. 2014.
15	He M-l, Liu J-j, Gu Y, L T-y and Chen J: Effects of inhibiting secretion of mesenchymal stem cells originated interleukin-6 on oxygen glucose deprivation injured PC12 cells. J Shanghai Jiaotong Uni (Sci). 34:1435–1447. 2014.
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
17	Gong M, Bi Y, Jiang W, Zhang Y, Chen L, Hou N, Liu Y, Wei X, Chen J and Li T: Immortalized mesenchymal stem cells: An alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies. J Biomed Sci. 18:872011. View Article : Google Scholar : PubMed/NCBI
18	Kishimoto T: Interleukin-6: Discovery of a pleiotropic cytokine. Arthritis Res Ther. 8(Suppl 2): S22006. View Article : Google Scholar : PubMed/NCBI
19	Kishimoto T: IL-6: From its discovery to clinical applications. Int Immunol. 22:347–352. 2010. View Article : Google Scholar : PubMed/NCBI
20	Woodcock T and Morganti-Kossmann MC: The role of markers of inflammation in traumatic brain injury. Front Neurol. 4:182013. View Article : Google Scholar : PubMed/NCBI
21	Arroyo DS, Soria JA, Gaviglio EA, Rodriguez-Galan MC and Iribarren P: Toll-like receptors are key players in neurodegeneration. Int Immunopharmacol. 11:1415–1421. 2011. View Article : Google Scholar : PubMed/NCBI
22	Wang YC, Lin S and Yang QW: Toll-like receptors in cerebral ischemic inflammatory injury. J Neuroinflammation. 8:1342011. View Article : Google Scholar : PubMed/NCBI
23	Vogel SN, Fitzgerald KA and Fenton MJ: TLRs: Differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv. 3:466–477. 2003. View Article : Google Scholar
24	Marsh BJ, Williams-Karnesky RL and Stenzel-Poore MP: Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience. 158:1007–1020. 2009. View Article : Google Scholar :
25	Crack PJ and Bray PJ: Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol. 85:476–480. 2007. View Article : Google Scholar : PubMed/NCBI
26	Mohamed MR and McFadden G: NFκB inhibitors: Strategies from poxviruses. Cell Cycle. 8:3125–3132. 2009. View Article : Google Scholar : PubMed/NCBI
27	Takeda K and Akira S: Toll-like receptors in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar
28	Akhmatova NK, Egorova NB, Kurbatova EA and Akhmatov EA: Activation of innate immunity by bacterial ligands of toll-like receptors. Front Immunol. 5:892014. View Article : Google Scholar : PubMed/NCBI